Skip to main content
SpringerLink
Log in

New approaches in the use of radiation therapy in the treatment of infiltrative transitional-cell cancer of the bladder

  • Published:
World Journal of Urology Aims and scope Submit manuscript

Summary

Organ preservation using primary radical radiation therapy (RT) is a viable treatment option for many patients with invasive bladder cancer, and there is no evidence that survival is compromised by this approach. However, the survival and local control rates in patients with bladder cancer currently treated with radical RT are not optimal. Combined modality therapy, altered radiation-fractionation approaches, and exciting new approaches such as the application of gene therapy and the use of hypoxic cell sensitisers, among others, may well improve the results of treatment in the future. Ongoing clinical research, including prospective randomised trials, will be required to evaluate these new approaches to therapy.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Ang K, Trotti A, Garden A, Foote R, Morrison W, Geara F, Peters L (1996) Overall time factor in postoperative radiation: results of a prospective randomized trial. Radiother Oncol 40 Suppl 1: S30

    Google Scholar 

  2. Blandy JP. England HR, Evans SJW, Hope SHE, Mair GMM, Mantell BS, Oliver RTD, Paris AMI, Risdon RA (1980) T3 Bladder cancer—the case for salvage cystectomy. Br J Urol 52: 506–510

    Google Scholar 

  3. Blandy JP, Jenkins BJ, Fowler CG, Caulfield M, Badenoch DF, England HR, Hope-Stone HE, Mair GM, Mantell BS, Oliver RT, et al (1988) Radical radiotherapy and salvage cystectomy for T2/3 cancer of the bladder. Prog Clin Biol Res 260: 447–451

    Google Scholar 

  4. Bristow R, Benchimol S, Hill RP (1996) The p53 gene as a modifier of intrinsic radiosensitivity: implications for radiotherapy. Radiother Oncol (in press)

  5. Coleman CN, Stevenson MA (1996) Advances in cellular and molecular radiation oncology. Urol Onco 2: 3–13

    Google Scholar 

  6. Coppin C, Brown E (1986) Concurrent cisplatin with radiation for locally advanced bladder cancer: a pilot study suggesting improved survival. Proc Am Soc Clin Oncol 5: 99

    Google Scholar 

  7. Coppin C; Gospodarowicz MK, James K, Tannock IF, Zee B, Pater J, Sullivan LD (1996) Improved local control of invasive bladder cancer by concurrent cisplatin and preoperative or definitive radiation. J Clin Oncol 14: 2901–2907

    Google Scholar 

  8. Davidson SE, Symonds RP, Snee MP, Upadhyay S, Habeshaw T, Robertson AG (1990) Assessment of factors influencing the outcome of radiotherapy for bladder cancer. Br J Urol 66: 288–293

    Google Scholar 

  9. Duncan W, Quilty PM (1986) The results of a series of 963 patients with transitional cell carcinoma of the urinary bladder primarily treated by radical megavoltage X-ray therapy. Radiother Oncol 7: 299–310

    Google Scholar 

  10. Dunst J, Sauer R, Schrott KM, Kuhn R, Wittenkind C, Altendorf-Hofman A (1994) Organ sparing treatment of advanced bladder cancer: a 10 year experience. Int J Radiat Oncol Biol Phys 30: 261–266

    Google Scholar 

  11. Eapen L, Stewart D, Crook J, Aitken S, Danjoux C, Rasuli P, Peterson R (1992) Intraarterial cisplatin and concurrent pelvic radiation in the management of muscle invasive bladder cancer. Int J Radiat Oncol Biol Phys 24 [Suppl 1]: 211

    Google Scholar 

  12. Evans PE, Swanson DA, (1996) What to do if the lymph nodes are positive. Semin Urol Oncol 14: 96–102

    Google Scholar 

  13. Fossa SD, Waehre H, Aass N, Jacobsen AB, Olsen DR, Ous S (1993) Bladder cancer: definitive radiation therapy of muscle-invasive bladder cancer. A retrospective analysis of 317 patients. Cancer 72: 3036–3043

    Google Scholar 

  14. Fujiwara T, et al (1994) Induction of chemosensitivity in human lung cancer cells in vivo by adenoviral mediated transfer of the wild type p53 gene. Cancer Res 54: 2287–2291

    Google Scholar 

  15. Fung CY, Shipley WU, Young RH, Griffin PP, Convery KM, Kaufman DS, Althausen AF, Heney NM, Prout GR Jr (1991) Prognostic factors in invasive bladder carcinoma in a prospective trial of preoperative adjuvant chemotherapy and radiotherapy [see comments]. J Clin Oncol 9: 1533–1542

    Google Scholar 

  16. Fyles A, Keane T, Barton M, Simm J (1992) The effect of treatment duration in the local control of cervix cancer. Radiother Oncol 25: 273–279

    Google Scholar 

  17. Gospodarowicz MK, Hawkins NV, Rawlings GA, Connolly JG, Jewett MAS, Thomas GM, Herman JG, Garrett DG, Chua T, Duncan W, Buckspan M, Sugar L, Rider WD (1989) Radical radiotherapy for muscle invasive transitional cell carcinoma of the bladder: Failure analysis. J Urol 142: 1448–1454

    Google Scholar 

  18. Gospodarowicz MK, Rider WD, Keen CW, Connolly JG, Jewett MAS, Cummings BJ, Duncan W, Warde P, Chua T (1997) Bladder cancer: long term follow-up results of patients treated with radical radiation. Clin Oncol 3: 155–161

    Google Scholar 

  19. Gospodarowicz MK, Quilty PM, Scalliet P, Tsujii H, Fossa SD, Horenblas S, Isaka S, Prout GR, Shipley WU, Wijnmaalen AJ, et al (1995) The place of radiation therapy as definitive treatment of bladder cancer (review). Int J Urol 41: 41–48

    Google Scholar 

  20. Hall R (1996) Neo-adjuvant CMV chemotherapy and cystectomy or radiotherapy in muscle invasive bladder cancer. First analysis of MRC/EORTC intercontinental trial. Proc Am Soc Clin Oncol 15: 244

    Google Scholar 

  21. Hallahan DE, Maucera HJ, Seug LP, et al (1995) Spatial and temporal control of gene therapy using ionising radiation. Nat Med 1: 786–791

    Google Scholar 

  22. Honnens DE, Lichtenberg M, Miskowiak J, Rolff H (1995) Results of radiotherapy on ureteric obstruction in muscle-invasive bladder cancer. Br J Urol 75: 197–199

    Google Scholar 

  23. 23.Horiot J, Bontemps P, Le Fur R, Bogaert W van de, Bolla M, Weijngaert D van, Bernier J, Lusinchi A, Stuschke M, Lopez Torrecilla D, Collette L, Pierart M (1996) An overview of the EORTC accelerated and hyperfractionated radiotherapy trials in head and neck cancers. Radiother Oncol 40 [Suppl 1]: S30

    Google Scholar 

  24. Housset M, Maulard C, Chretien Y, Dufour B, Delanian S, Huart J, Colardelle F, Brunel P, Baillet F (1993) Combined radiation and chemotherapy for invasive transitional-cell carcinoma of the bladder: a prospective study. J Clin Oncol 11: 2150–2157

    Google Scholar 

  25. Jacobsen AB, Pettersen EO, Amellem O, Berner A, Ous S, Fossa SD (1992) The prognostic significance of deoxyribonucleic acid flow cytometry in muscle invasive bladder carcinoma treated with preoperative irradiation and cystectomy. J Urol 147: 34–37

    Google Scholar 

  26. Jakse G, Frommhold H (1985) Radiotherapy and chemotherapy in locally advanced bladder cancer. Eur Urol 14 [Suppl 1]: 45

    Google Scholar 

  27. Jenkins BJ, Martin JE, Baithun SI, Zuk RJ, Oliver RTD, Blandy JP (1990) Prediction of response to radiotherapy in invasive bladder cancer. Br J Urol 65: 345–348

    Google Scholar 

  28. Koratim M, Kamal B, Metwalli N, Zaky Y (1995) Transurethral ultrasonographic assessment of bladder carcinoma: its value and limitation. J Urol 154: 375–378

    Google Scholar 

  29. Lynch W, Jenkins BJ, Fowler CG, Hope SH, Blandy JP (1992) The quality of life after radical radiotherapy for bladder cancer. Br J Urol 70: 519–521

    Google Scholar 

  30. Malmstrom PU, Lonnemark M, Busch C, Magnusson A (1993) Staging of bladder carcinoma by computer tomography-guided transmural core biopsy. Scand J Urol Nephrol 27: 193–198

    Google Scholar 

  31. Mameghan H, Fisher R, Mameghan J, Brook S (1995) Analysis of failure following definitive radiotherapy for invasive transitional cell carcinoma of the bladder. Int J Radiat Oncol Biol Phy 31: 247–254

    Google Scholar 

  32. Martin JE, Jenkins BJ, Zuk RJ, Oliver RT, Baithun SI (1989) Human chorionic gonadotrophin expression and histological findings as predictors of response to radiotherapy in carcinoma of the bladder. Virchows Arch [A] 414: 273–277

    Google Scholar 

  33. Monzen Y, Mori H, Matsumoto S, Takaki H, Yoshida S, Wakisaka M, Ueda S, Mizoguchi H, Ogata J, Kato Y (1995) Intraarterial infusion of cisplatin with and without preoperative concurrent radiation for urinary bladder cancer: a preliminary report. Radiat Med 13: 149–152

    Google Scholar 

  34. Moonen LM, Horenblas S, Voet JC van der, Nuyten MJ, Bartelink H (1994) Bladder conservation in selected T1G3 and muscle-invasive T2-T3a bladder carcinoma using combination therapy of surgery and iridium-192 implantation. Br J Urol 74: 322–327

    Google Scholar 

  35. Moore MJ, O'Sullivan B, Tannock IF (1988) How expert physicians would wish to be treated if they had genitourinary cancer. J Clin Oncol 6: 1736–1745

    Google Scholar 

  36. Naslund I, Nilsson B, Littbrand B (1994) Hyperfractionated radiotherapy of bladder cancer. A ten-year follow-up of a randomized clinical trial. Acta Oncol 33: 397–402

    Google Scholar 

  37. Overgaard J (1994) Clinical evaluation of nitroimidazoles as modifiers of hypoxia in solid tumours. Oncol Res 6: 509–518

    Google Scholar 

  38. Pagano F, Bassi P, Galetti TP, Meneghini A, Milani C, Artibani W, Garbeglio A (1991) Results of contemporary radical cystectomy for invasive bladder cancer: a clinicopathological study with an emphasis on the inadequacy of the tumour, nodes and metastases classification. J Urol 145: 45–50

    Google Scholar 

  39. Paschkis R (1911) Radiumbehandlung von Blasengeschwulsten. Wien Klin Wochenschr 24: 1962

    Google Scholar 

  40. Pisters LL, Tykochinsky G, Wajsman Z (1991) Intravesical bacillus Calmette-Guérin or mitomycin C in the treatment of carcinoma in situ of the bladder following prior pelvic radiation therapy. J Urol 146: 1514–1517

    Google Scholar 

  41. Plataniotis G, Michalopoulos E, Kouvaris J, Vlahos L, Papavasiliou C (1994) A feasibility study of partially accelerated radiotherapy for invasive bladder cancer. Radiother Oncol 33: 84–87

    Google Scholar 

  42. Pollack A, Zagars GK, Dinney CP, Swanson DA, von Escrenbach AC Preoperative radiotherapy for muscle-invasive bladder carcinoma. Long term follow-up and prognostic factors for 338 patients. Cancer 74: 2819–2827

  43. Pollack A, Zagars GK, Swanson DA (1994) Muscle-invasive bladder cancer treated with external beam radiotherapy: prognostic factors. Int J Radiat Oncol Biol Phys 30: 267–277

    Google Scholar 

  44. Pollack A, Zagars GK, Cole CJ, Dinney CPN, Swanson DA, Crossman HB (1995) The relationship of local control to distant metastasis in muscle invasive bladder cancer. J Urol 154: 2059–2064

    Google Scholar 

  45. Priesler H, Kotelnikov V, LaFollette S, Taylor S, et al (1996) Continued malignant cell proliferation in head and neck tumours during cytoxic therapy. Clin Cancer Res 2: 1453–1460

    Google Scholar 

  46. Quilty PM, Duncan W (1986) Radiotherapy for squamous carcinoma of the urinary bladder. Int J Radiat Oncol Biol Phys 12: 861–865

    Google Scholar 

  47. Quilty PM, Kerr GR, Duncan W (1986) Prognostic indices for bladder cancer: an analysis of patients with transitional cell carcinoma of the bladder primarily treated by radical megavoltage X-ray therapy. Radiother Oncol 7: 311–321

    Google Scholar 

  48. Roth JA, et al (1996) Retrovirus-mediated wild type p53 gene transfer to tumours of patients with lung cancer. Nat Med 2: 985–987

    Google Scholar 

  49. Rotman M, Aziz H, Porrazzo M, Choi K, Silverstein M, Rosenthal J, Laungani G, Macchia R (1990) Treatment of advanced transitional cell carcinoma of the bladder with irradiation and concomitant 5-fluorouracil infusion. Int J Radiat Oncol Biol Phys 18: 1131–1137

    Google Scholar 

  50. Russell KJ, Boileau MA, Higano C, Collins C, Russell AH, Koh W, Cole SB, Chapman WH, Griffin TW (1990) Combined 5-fluorouracil and irradiation for transitional cell carcinoma of the urinary bladder [see comments]. Int J Radiat Oncol Biol Phys 19: 693–699

    Google Scholar 

  51. Sauer R, Dunst J, Altendorf-Hofmann A, Fischer H, Bornhof C, Schrott KM (1990) Radiotherapy with and without cisplatin in bladder cancer. Int J Radiat Oncol Biol Phys 19: 687–691

    Google Scholar 

  52. See WA, Fuller JR (1992) Staging of advanced bladder cancer. Current concepts and pitfalls (review). Urol Clin North Am 19: 663–683

    Google Scholar 

  53. Shipley WU, Coombs LJ, Einstein AB Jr, Soloway MS, Wajsman Z, Prout G Jr, et al (1984) Cisplatin and full dose irradiation for patients with invasive bladder carcinoma: a preliminary report of tolerance and local response. J Urol 132: 899–903

    Google Scholar 

  54. Shipley WU, Kaufman DS, Griffin P, Althausen AF, Heney NM, Prout GJ (1992) Radio-chemotherapy for invasive carcinoma of the bladder (review). Front Radiat Ther Oncol 26: 142–152

    Google Scholar 

  55. Smaaland R, Akslen L, Tonder B, Mehus A, Lote K, Albrektsen G (1991) Radical radiation treatment of invasive and locally advanced bladder cancer in elderly patients. Br J Urol 67: 61–69

    Google Scholar 

  56. Tannock I (1996) The treatment of cancer with radiation and drugs. J Clin Oncol (in press)

  57. Tester W, Porter A, Asbell S, Coughlin C, Heaney J, Martz K, Venner P, Hammond E (1989) Combined modality program with possible organ preservation for invasive bladder carcinoma: preliminary results of RTOG protocol 8512. Proc Am Soc Clin Oncol 8: 141

    Google Scholar 

  58. Turner SL, Swindell SL, Bowl N, et al (1994) Bladder movement during radiation therapy for bladder cancer: implications for treatment planning. Int J Radiat Oncol Biol Phys 30: 81

    Google Scholar 

  59. 59.Vale JA, A'Hern RP, Liu K, Hendry WF, Whitfield HN, Plowman PN, Sowter C, Slavin G (1993) Predicting the outcome of radical radiotherapy for invasive bladder cancer. Eur Urol 24: 48–51

    Google Scholar 

  60. Wolf H, Olsen PR, Hojgaard K (1985) Urothelial dysplasia concomitant with bladder tumours: a determinant for future new occurrences in patients treated by full-course radiotherapy. Lancet II: 1005–1008

    Google Scholar 

  61. Zietman AL; Shipley WU (1994) Organ-sparing treatment for bladder cancer: time to beat the drum (editorial). Int J Radiat Oncol Biol Phys 30: 741–742

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Radiation Oncology, Princess Margaret Hospital, 610 University Avenue, Toronto, Canada

    P. Warde

  2. Department of Radiation Oncology, University of Toronto, Toronto, Canada

    M. K. Gospodarowicz

Authors
  1. P. Warde
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. M. K. Gospodarowicz
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Warde, P., Gospodarowicz, M.K. New approaches in the use of radiation therapy in the treatment of infiltrative transitional-cell cancer of the bladder. World J Urol 15, 125–133 (1997). https://doi.org/10.1007/BF02201984

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02201984

Keywords

Search

Navigation